Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
British Journal of Clinical Pharmacology|May 22, 2012
Safety, tolerability and pharmacokinetics of single and multiple doses of a novel sigma-1 receptor antagonist in three randomized phase I studiesMontserrat Abadias, Marisol Escriche, Anna Vaqué, et al.
Regulatory Toxicology and Pharmacology : RTP|May 1, 2022
Results from two-year rodent oral carcinogenicity studies of cizolirtine, a substance-P and calcitonin gene-related peptide release modulatorAntonio Guzmán, Araceli Tortajada, Ana-Paz Marín, et al.
Frontiers in Veterinary Science|October 10, 2025
Enflicoxib for the long-term management of canine osteoarthritis-External validation of a population pharmacokinetic model in dogs with osteoarthritisJosep-Maria Cendrós, Marta Salichs, Gregorio Encina, et al.
Drug Metabolism Letters|December 10, 2021
Comparative In vitro Metabolism of Enflicoxib in Dogs, Rats, and Humans: Main Metabolites and Proposed Metabolic PathwaysJosep Solà, Àngel Menargues, Josep Homedes, et al.
Journal of Veterinary Pharmacology and Therapeutics|June 23, 2021
Pharmacokinetics of enflicoxib in dogs: Effects of prandial state and repeated administrationJosep Homedes, Marta Salichs, Josep Solà, et al.
Regulatory Toxicology and Pharmacology : RTP|March 12, 2021
Twenty six-week repeat dose oral rat toxicity study of cizolirtine, a substance-P and calcitonin gene-related peptide release modulatorAntonio Guzmán, Gregorio Encina, Antonio R Fernández de Henestrosa, et al.
Expert Opinion on Investigational Drugs|April 27, 2019
Co-crystal of tramadol-celecoxib: preclinical and clinical evaluation of a novel analgesicNeus Gascon, Carmen Almansa, Manuel Merlos, et al.
Pageof 2